Literature DB >> 18461061

Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis.

Josef S Smolen1, Daniel Aletaha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18461061     DOI： 10.1038/ncprheum0813

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  3 in total

Review 1.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

2.  α-Mangostin Alleviated HIF-1α-Mediated Angiogenesis in Rats With Adjuvant-Induced Arthritis by Suppressing Aerobic Glycolysis.

Authors:  Tian-Tian Jiang; Chao-Fan Ji; Xiu-Ping Cheng; Shao-Fei Gu; Rui Wang; Yan Li; Jian Zuo; Jun Han
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

3.  Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

Authors:  Tracey M Farragher; Mark Lunt; Bo Fu; Diane Bunn; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-26       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.